Safety and Performance of DKL Crosslinked Sodium Hyaluronate 23 Dermal Filler for Improvement of NLF Appearance

NCT05021913 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Aging, Premature

Interventions

DEVICE: DKL crosslinked sodium hyaluronate 23
DEVICE: Juvéderm Volift™ with lidocaine (Allergan, Inc)

Sponsor

Dr. Korman Laboratories Ltd.

Collaborators

[object Object]